Source: Getty Images Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection. Serum PSA testing is not specific to prostate cancer, and ...

PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. To confirm the diagnosis, biopsies are required. A team of researchers has now ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers ...

Early detection of prostate cancer is crucial, as this disease can be so indolent (slow-growing) that patients don't realize they have it until it causes significant problems. The good news is that if ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...

Prostate cancer screenings slash the risk of dying from the disease in the following decades, according to new research. The screening measures the amount of prostate-specific antigen (PSA) in men’s ...

Black men have a higher risk of prostate cancer. Surgery is sometimes the best treatment option for certain tumors. MSK ...

The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

SEATTLE — September marks Prostate Cancer Awareness Month, a time to shine a light on one of the most common cancers affecting men. Fortunately, when caught early, prostate cancer is also one of the ...

INDIANAPOLIS — September is Prostate Cancer Awareness Month, and for millions of men across the country, it's is a crucial reminder about the importance of early detection. Dr. Sandeep Bhave, a ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...